0001062993-22-018004.txt : 20220815
0001062993-22-018004.hdr.sgml : 20220815
20220815170345
ACCESSION NUMBER: 0001062993-22-018004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220811
FILED AS OF DATE: 20220815
DATE AS OF CHANGE: 20220815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walker Matthew Allen
CENTRAL INDEX KEY: 0001908721
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39894
FILM NUMBER: 221166535
MAIL ADDRESS:
STREET 1: C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
STREET 2: 200 BOSTON AVENUE, SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
FORMER NAME:
FORMER CONFORMED NAME: Walker Matthew Alan
DATE OF NAME CHANGE: 20220202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC
CENTRAL INDEX KEY: 0001822691
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851914700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
BUSINESS PHONE: (617) 616-8188
MAIL ADDRESS:
STREET 1: 200 BOSTON AVENUE
STREET 2: SUITE 3100
CITY: MEDFORD
STATE: MA
ZIP: 02155
FORMER COMPANY:
FORMER CONFORMED NAME: Environmental Impact Acquisition Corp
DATE OF NAME CHANGE: 20200826
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-08-11
0001822691
GreenLight Biosciences Holdings, PBC
GRNA
0001908721
Walker Matthew Allen
C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC
200 BOSTON AVENUE, SUITE 3100
MEDFORD
MA
02155
1
0
1
0
Common Stock
2022-08-11
4
P
0
63775
3.92
A
63775
D
Common Stock
2022-08-11
4
P
0
6377551
3.92
A
22220572
I
by Builders Vision, LLC
Consists of 63,775 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and Matthew Allen Walker.
Includes 6,377,551 shares of Common Stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, LP ("Fund III").
Total number of shares beneficially owned by the Reporting Person includes: (i) 11,551,245 shares held by Fund III; (ii) 2,087,043 shares held by S2G Ventures Fund I, L.P. ("Fund I"); and (iiii) 8,582,284 shares held by S2G Ventures Fund II, L.P. ("Fund II" and, together with Fund I, and Fund III, the "S2G Funds"). Builders Vision, LLC is the Manager of Fund I and Fund II, and the General Partner of Fund III, and has power to vote or direct the voting of shares held by the S2G Funds. The General Partners of Fund I and Fund II are S2G Ventures, LLC and S2G Ventures II, LLC, respectively.
(Continued) Mr. Walker, a director of the Issuer, is a Managing Director of Builders Vision, LLC, the impact platform founded by Lukas T. Walton, which includes S2G Ventures. By virtue of the foregoing, S2G Ventures, LLC and S2G Ventures II, LLC, Mr. Walker and Mr. Walton may be deemed to indirectly beneficially own (as defined in Rule 13d-3 of the Exchange Act) the shares of Common Stock held by the S2G Funds. Mr. Walker and Mr. Walton each disclaims beneficial ownership of these shares of Common Stock except to the extent of any pecuniary interest therein.
/s/ David Kennedy, Attorney-in-fact for Matthew Allen Walker
2022-08-15